MRK
Merck & Company Inc
Merck & Company Inc historical holders
total: 18
Fairfax Financial Holdings Merck & Company Inc transactions over time
- Total transactions:
- 2
- New positions:
- 1
- Added:
- 1
- Held since:
- 2020 Q4
- Held for:
- 22 quarters
- Latest activity:
- 2021 Q1
Prem Watsa has been an institutional investor in Merck & Company Inc (MRK) since 2020 Q4. According to 2026 Q1 report, Prem Watsa holds 172,900 shares with a market value of roughly $20.80M representing 1.07% of their equity portfolio. The fund/company first acquired MRK in 2020 Q4, initially purchasing 122,900 shares. Since the initial investment, Fairfax Financial Holdings has made 1 more transaction in this position.
Does Prem Watsa still hold MRK?
Yes, Prem Watsa continues to hold Merck & Company Inc (MRK). According to their 2026 Q1 report, they maintain a position of 172,900 shares valued at approximately $20.80M, representing 1.07% of their equity portfolio.
When did Prem Watsa first invest in MRK?
Prem Watsa first invested in Merck & Company Inc (MRK) in 2020 Q4 at the reported quarter-end price of $81.80 per share, acquiring 122,900 shares in their initial purchase.
What is Prem Watsa's average cost basis for MRK?
Based on historical transaction data, Prem Watsa's estimated cost basis for Merck & Company Inc (MRK) is approximately $80.44 per share. This represents their average reported price* across all buy transactions.
Estimated cost basis*
- Weighted AVG buy price:
- $80.44
* Shares, change to shares, sold shares, shares held after: split-adjusted.
* Reported price: this doesn't represent the actual buy or sell price. It is the split-adjusted price of the security as of the last day of the reported period.
If the security is completely sold out, we show the reported split-adjusted price prior to the actual period.
If the security is completely sold out, we show the reported split-adjusted price prior to the actual period.
* Estimated cost basis: based on "Reported price*" (not earlier than 2013 Q2). Calculation starts from the latest "new buy" activity to the latest "close out" activity (if any).
* Value or Price: If the security is completely sold out, we show the reported value (or price) prior to the actual period.
* New buy or own: this means there is no earlier reporting (for us or in general). So we can't know if the actual purchase of the security happened at the reported period or earlier.